Pfizer Ltd Forensic Report - SOIC x StockScans Report

as of Jul 2026

Pfizer Ltd’s record carries seven years of clean audit opinions and a stable, zero-pledge promoter holding. Three things deserve attention: a single domestic customer supplies over 70% of revenue and its receivable has nearly tripled in a year; disputed tax and pricing demands total ₹379.69 crore; and the board has recommended a ₹343 crore dividend against standalone PAT of ₹137 crore, a payout funded by accumulated reserves and past asset-sale gains.

Key findings

  1. A single domestic customer contributes over 70% of revenue, and its receivable nearly tripled in a year Major - One domestic customer contributed ₹568.57 crore of total revenue in FY2025-26, over 70% of standalone revenue of ₹797 crore. The receivable from that customer rose to ₹56.23 crore as at 31 March 2026 from ₹19.18 crore a year earlier, a 193% increase. Revenue recognition has been identified as a Key Audit Matter, an area requiring the most judgement, in each of the last four annual reports, with auditors citing risk of overstatement to meet performance targets.
  2. Exceptional items swing reported profit sharply, with a net charge of ₹49.16 crore in FY2026 after a net gain of ₹172.81 crore in FY2025 Major - Exceptional items swung from a net gain of ₹172.81 crore in FY2025, driven by the sale of Thane leasehold rights and building to Zoetis, to a net charge of ₹49.16 crore in FY2026, comprising ₹41.73 crore in personnel separation cost for field force restructuring and ₹7.43 crore provision for new Labour Codes. Inventory write-down charges rose from ₹11.34 crore in FY2025 to ₹28.46 crore in FY2026.
  3. Dividends have repeatedly been set above standalone PAT, with the FY2026 recommended dividend of ₹343 crore against PAT of ₹137 crore Major - The Board recommended a final dividend of ₹75 per share, or ₹343.11 crore, for FY2026, subject to shareholder approval at the AGM on July 28, 2026. Standalone PAT was ₹722 crore in FY2025 and ₹137 crore in FY2026, while the FY2026 recommended dividend alone is ₹343.11 crore [SQL]. Total dividend payout for FY2025 was ₹754.84 crore, comprising a final dividend of ₹35 per share and two special dividends funded by the gain on sale of Thane leasehold land and buildings to Zoetis.
  4. A legacy ₹2.50 crore interest-free unsecured loan to a promoter entity persists unresolved for over six years Minor - A ₹2.50 crore purchase consideration payable to related party John Wyeth and Brother Limited, UK, has been retained as an interest-free unsecured loan per RBI directives pending clearance from income tax authorities, reported identically in each annual report from FY2020-21 through FY2025-26. Trade payables outstanding to related parties rose from ₹23.51 crore as of 31 March 2025 to ₹83.51 crore as of 31 March 2026.
  5. Clean audit opinions across seven years, with a payroll-backup exception and a new audit-trail gap Minor - The standalone audit opinion and internal financial controls opinion were unqualified every year from FY2020 through FY2026. The auditor reported that the back-up of the payroll software was not kept on servers physically located in India in FY2024, FY2025, and FY2026; a related exception regarding daily back-up of books of account on servers in India was also reported in FY2023. From FY2024 onward, the auditor reported that the audit-trail feature was not enabled at the application level for certain fields in the general ledger accounting software.
  6. Promoter holds 63.92% with zero pledge; executive pay escalated sharply in FY2025-26 via commission Minor - Promoter shareholding remained at 63.92% in FY2025-26 with 0.00% of shares pledged. Ms. Meenakshi Nevatia, Managing Director, received total remuneration of ₹13.42 crore in FY2025-26, up from ₹1.83 crore in FY2023-24, driven by a ₹12.00 crore commission. The three Executive Directors held zero equity shares of the Company as of March 31, 2026.
  7. Statutory auditor rotated on schedule; cost auditor resigned mid-term after a partner inherited company shares; no actions against any auditor are reported Clean - Walker Chandiok & Co LLP completed a five-year term at the 71st AGM in FY2021-22, and B S R & Co. LLP was appointed as statutory auditor for a five-year term. Cost auditor M/s. R.A. & Co. resigned on 18 March 2024, citing ineligibility after partner Mr. Rasesh Chokshi inherited shares of the Company. M/s. Kishore Bhatia & Associates was appointed as cost auditor on 11 April 2024 to fill the casual vacancy.

What to watch

Bottom line: This is a disclosed and audited record with seven years of clean opinions and a stable, zero-pledge promoter. The risk sits in three places: a single-customer concentration that sets both the pace of revenue and the pace of collection, a dividend policy that draws on reserves and asset-sale gains rather than current earnings, and a litigation load of DPCO demands of ₹153.17 crore and sales tax/VAT demands of ₹226.52 crore that keeps the contingent-liability note thick. Read the receivables line and the dividend cover together.